Sunwin Stevia International, Inc. Reports Earnings Results for the Second Quarter Ended October 31, 2020
December 11, 2020 at 01:08 pm EST
Share
Sunwin Stevia International, Inc. announced earnings results for the second quarter ended October 31, 2020. For the second quarter, the company announced total revenue was USD 4.433 million compared to USD 7.161 million a year ago. Operating loss was USD 604,191 compared to operating income of USD 350,532 a year ago. Net loss was USD 403,380 compared to net income of USD 191,891 a year ago. For the half year, total revenue was USD 11.473 million compared to USD 14.051 million a year ago. Operating loss was USD 1.582 million compared to operating income of USD 388,394 a year ago. Net loss was USD 1.065 million compared to USD 191,344 a year ago. Basic loss per share was USD 0.01.
Sunwin Stevia International, Inc. sells stevioside, a natural sweetener, and herbs used in traditional Chinese medicines and veterinary products. The Company operates through two segments related to its product lines: Stevioside, which produces and sells a range of purified steviol glycosides with rebaudioside A and stevioside as the principal components; a natural, low calorie sweetener, and OnlySweet, a stevioside-based table top sweetener, and Chinese medicines, which manufactures and sells traditional Chinese medicine formula extracts, which are used in products made for use by both humans and animals. The Company engages in new product development both through its internal research facilities, industry consultants and specialists to provide research and development for the planting of stevia plants, for the development of biological methods to improve lower-grade stevia product to higher-grade stevia, and for the application of biological method to change the taste of stevia.
SUNWIN STEVIA INTERNATIONAL, INC. 
